New ADHD Drug Approved in UK

BBC Radio 4’s Today Programme had a piece this morning on ADHD and a new drug, amoxetine, that has been approved for us it UK. There is also coverage on the BBC News site.
Amoxetine (marketed as Strattera) main selling points are that a single dose lasts 24 hours (significantly longer than Ritalin), it apparently has no side effects and it is less prone to being abused as it is not a stimulant, unlike Ritalin.

Find Out More:

Books:

Concerta Side Effects
Ritalin Is Not The Answer: A Drug-Free, Practical Program for Children Diagnosed with ADD or ADHD
Talking Back to Ritalin: What Doctors Aren’t Telling You About Stimulants and ADHD
Beyond Ritalin: Facts About Medication and Other Strategies for Helping Children, Adolescents, and Adults with Attention Deficit Disorders
Ritalin is Not the Answer Action Guide: An Interactive Companion to the Bestselling Drug-Free ADD/ADHD Parenting Program

June 3rd, 2004
ADD / ADHD Medication, ADD / ADHD

ADHD Boarding Schools

Pharmaceuticals GMP Procedures

Moving

Child Development

Natural ADHD Treatments

Discuss the topics raised by this article on the Myomancy Forum.

Google Search

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

Myomancy Treatment Database

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner:

Myomancy ADHD, Dyslexia and Autism